Fernando Wladimir Silva Rivas

Fernando Wladimir Silva Rivas

Auto-generated profile, based on publicly available information

Fernando Wladimir Silva Rivas

Universidade de São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2024 in Clinics
Verified
Journal Article
Open access
FRFernando Wladimir Silva Rivas
Fernando Wladimir Silva Rivas
RGRodrigo Gonçalves
Rodrigo Gonçalves
BMBruna Salani Mota
Bruna Salani Mota
Isabel SorpresoIsabel Sorpreso
Isabel Sorpreso
TTTatiana Natasha Toporcov
Tatiana Natasha Toporcov
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
Brazil faces notable Breast Cancer (BC) mortality despite lower incidence rates versus developed countries. Despite guidelines from medical societies, Brazilian public policy recommends biennial mammographic screening for women aged 50 to 69. This study investigates sociodemographic and clinical factors related to BC detection methods and clinical stage at diagnosis. The authors conducted a cross-sectional study at a São Paulo tertiary hospital. Patients were divided into 'symptomatic' and 'mammographic' detection groups. Bivariate analyses by detection method and clinical stage compared groups' profiles in terms of sociodemographic and clinical characteristics. Poisson regression analyses assessed sociodemographic and molecular subtypes´ influence on "mammographic detection" prevalence and "advanced-stage BC", reporting prevalence ratios and 95 % Confidence Intervals. The authors studied 1,536 BC patients admitted from January 2016 to December 2017. The "mammographic detection" group had a higher proportion of patients aged 50‒69 years (62.9 % vs. 44.1 %), white race (63.3 % vs. 51.6 %), Catholic religion (58.2 % vs. 51.1 %), and Luminal A subtype (25.2 % vs. 13.2 %) compared to the "symptomatic detection" group. Patients with early-stage disease were more likely to have higher education levels (8.1 % vs. 5.5 %) and be married (39.8 % vs. 46.6 %) compared to those with advanced-stage. Molecular subtypes were significantly associated with the detection method and stage. The prevalence of advanced-stage disease in "mammographic" (n=313) and "symptomatic" (n=1191) groups was 18.5 % and 55 %, respectively . Mammographic detection significantly reduced advanced-stage BC prevalence (PR = 0.40, 95 % CI 0.31‒0.51). Mammographic detection reduces advanced-stage breast cancer prevalence in Brazil, emphasizing the importance of regular screenings, especially among at-risk sociodemographic groups. Enhancing mammographic screening accessibility, lowering the starting age to 40, and extending coverage to include annual mammograms can significantly lower breast cancer mortality in Brazil, benefiting public health and patient outcomes.

15 December 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGArlete Gianfaldoni
Arlete Gianfaldoni
CRCristiane Roa
Cristiane Roa
RSRicardo Dos Santos Simões
Ricardo Dos Santos Simões
MBMaria Cândida P Baracat
Maria Cândida P Baracat
AFAngela Maggio da Fonseca
Angela Maggio da Fonseca
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr
Intrauterine synechiae (IS) is an acquired uterine condition that occurs when scar tissues (adhesions) form within the uterus and/or cervix, causing menstrual disturbance. However, approximately 50% of patients with IS are refractory to treatment. Therefore, other endocrine disturbances, such as gonadotropin disturbance, may affect treatment success. To analyze gonadotropin levels in women with and without IS. Ten women with refractory IS experiencing amenorrhea since at least 6 months and nine with normal menstrual cycles (control group) were included in this study. Blood sample were collected every 10 minutes during a 4-h period. The serial ultrasound was performed in both groups for evaluating the cycle phase. Blood was collected when the follicles size was between 5–10 mm. Serum LH, FSH, progesterone and estradiol concentrations were measured. To detect LH and FSH pulses, the technique proposed by Santen and Bardin was adopted; therefore, one pulse was defined as a 20% increase in the concentrations as to the preceding point, followed by an important decrease. No differences were observed between the study groups at baseline. Estradiol levels were lower in the IS group than in the control group, but the difference was not statistically significant. During the first hour of monitoring, cumulative FSH pulsatile frequency of IS group was lower than one of control. Our data suggest that the estradiol levels of IS participants are lower than those of women with normal menstrual cycle. The role of this finding in the physiology of uterine synechiae requires further investigation.

19 February 2020 in Revista de Ciências Gerenciais
Verified
Journal Article
Open access
PDF file
GRGiuliano Carlo Rainatto
Giuliano Carlo Rainatto
OSOrlando Roque Silva
Orlando Roque Silva
DPDenis Gustavo Paschoal
Denis Gustavo Paschoal
NANorberto Almeida Andrade
Norberto Almeida Andrade
FSFernando Silva
Fernando Silva
A patente é uma ferramenta importante para o inventor, pois concede a ele um monopólio temporário de exploração devido à novidade atingida durante as pesquisas para a invenção. Atualmente os inventores brasileiros têm 30 mil pedidos no INPI, que concede cerca de 900 pedidos por ano de patentes depositadas. Essa lacuna entre entrada e saída de patentes, ocorre muito por parte de um sistema lento e criado só para poder coexistir com outros modelos de proteção. A presente pesquisa teve o intuito de analisar o processo de patentes brasileiro, valendo-se da ótica da informação, observando se a mesma é responsável pela fuga de pedidos de patentes do Brasil para o exterior. Foi utilizada uma pesquisa quali-quantitativa, com questionário apresentado via web, e também um roteiro de entrevista semiestruturada, visando identificar o que os inventores percebiam no ambiente informacional do INPI. Foi possível identificar que existe um gap entre a percepção e a expectativa da informação vinda do INPI para os inventores, criando um ruído em todo o processo de patenteamento. As entrevistas efetuadas corroboram com o questionário quantitativo, pois mostraram o descontentamento tanto ao volume quanto à qualidade e à velocidade da informação apresentada pelo INPI. Esses dados são suficientes para mostrar que o processo de patentes brasileiro, na ótica da informação, é muito ruim, pois, após longos anos de espera, a expectativa do inventor é muito distante da percepção. Palavras-chave: Patentes. Proteção Industrial. SERVQUA. Vantagem Competitiva. AbstractA patent is an important tool for the inventor as it gives him a temporary monopoly of exploitation due to the novelty achieved during research for the invention. Currently Brazilian inventors have 30,000 applications at the INPI, which grants about 900 patent applications per year filed. This gap between patent entry and exit occurs largely from a slow system designed just to coexist with other protection models. This research aimed to analyze the Brazilian patent process, using the information perspective, observing if it is responsible for the escape of patent applications from Brazil to abroad. A qualitative and quantitative research was used, with a questionnaire presented via the web, as well as a semi-structured interview script, aiming to identify what the inventors perceived in the informational environment of the INPI. It was possible to identify that there is a gap between the perception and expectation of the information coming from the INPI to the inventors, creating a noise throughout the patenting process. The interviews carried out corroborate the quantitative questionnaire, as they showed discontent regarding both the volume and the quality and speed of the information presented by the INPI. These data are sufficient to show that the Brazilian patent process, from an information point of view, is very bad, because after long years of waiting, the inventor's expectation is very far from perception. Keywords: Patents. Industrial Protection. SERVQUAL. Competitive Advantage.

8 November 2026 in JACCP: Journal of the American College of Clinical Pharmacy
Verified
Journal Article
Open access
MRMônica Cristina Dutra Rodrigues
Mônica Cristina Dutra Rodrigues
VMVictor Kaneko Matsuno
Victor Kaneko Matsuno
FRFernando Wladimir Silva Rivas
Fernando Wladimir Silva Rivas
LPLeonardo Pereira
Leonardo Pereira
Background: Pharmacist interventions (PIs) are vital for patient safety in pediatric intensive care units (PICUs). However, linking these recommendations to definitive outcomes like mortality remains limited by methodological challenges. This study evaluated the association of cumulative PIs and interprofessional team adherence with survival among patients requiring pharmacotherapeutic optimization who received at least one PI. Methods: A retrospective cohort study was conducted with 565 patients admitted to a tertiary PICU (2019–2021) with a stay > 24 h who received at least one documented PI. To account for the time‐varying nature of exposures and attenuate confounding, total PIs and accepted pharmacist interventions (aPIs) were modeled exploring their interaction with time using extended multivariable Cox proportional hazard models. Baseline clinical severity was adjusted using the Pediatric Index of Mortality‐2 score (PIM‐2). Data classification integrity was ensured through independent external validation (Cohen's kappa = 0.702). Results: Overall mortality was 11.9%, and total PIs presented an acceptance rate of 72.2%. In extended multivariable models, among patients who received at least one PI, cumulative total PIs were significantly associated with a lower hazard of in‐PICU mortality (hazard ratio [HR] = 0.989; p = 0.040), an association predominantly observed in non‐surgical patients (HR = 0.951; p = 0.029). Interprofessional adherence was more strongly associated with survival; cumulative PIs had a significant association with survival across the entire cohort (HR = 0.983; p = 0.025), remaining consistent in both surgical (HR = 0.983; p = 0.041) and non‐surgical strata (HR = 0.950; p = 0.043). Baseline clinical severity (PIM‐2 > 30%) remained the strongest independent predictor of death ( p < 0.001). Conclusion: Among patients requiring pharmacotherapeutic optimization who received at least one PI, cumulative pharmacist recommendations and interprofessional team adherence were independently associated with a lower time‐dependent hazard of in‐PICU mortality. Given the observational design, these findings reflect independent associations requiring prospective confirmation.

1 January 2025 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
FRFernando Wladimir Silva Rivas
Fernando Wladimir Silva Rivas
RGRodrigo Gonçalves
Rodrigo Gonçalves
EBEdmund Chada Baracat
Edmund Chada Baracat
José Maria  Soares-JrJosé Maria Soares-Jr
José Maria Soares-Jr